Introduction: Mosaic loss of chromosome Y (mLOY) is the most commonly detectable mosaic chromosomal event in cancers; however, its underlying relationship with tumorigenesis is still unclear.
Methods:
We conducted a mendelian randomization study to systematically investigate the effect of mLOY on lung cancer based on a published genome-wide association study and inferred the causal relationship between mLOY and lung cancer. Kaplan-Meier and Cox regression analyses were used to evaluate the effect of mLOY on lung cancer prognosis.
Results: We discovered that genetically defined mLOY was a protective factor against lung cancer development in nonsmokers but not in smokers ( ) to support the idea that heavy mLOY caused by acquired damaging environmental factors may have effects on lung cancer that are different from those of genetically defined mLOY, whereas genetically predicted mLOY was linearly associated with a decreased lung cancer risk (p for linearity Wald ¼ 0.15). In addition, increased genetically defined mLOY was also significantly associated with a better outcome of lung cancer (HR ¼ 0.86, 95% CI: 0.75-0.98, p ¼ 2.03 Â 10
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hematological diseases. [1] [2] [3] Recent observational studies investigated the association between the mLOY status and etiology of nonhematological cancers but failed to draw consistent conclusions: Forsberg et al. 4 proposed that men with mLOY have a substantially higher risk of cancer, whereas Wright et al. 5 and Zhou et al. 6 found little evidence of an association between mLOY and cancer risk. Zhou et al. 6 also showed inconsistent results within cancer types: mLOY was a risk factor for prostate and bladder cancer but exerted a protective effect against lung cancer risk, with a nonsignificant p value. However, because smoking can causally lead to lung cancer 7 and alter the status of mLOY, 8 the effect of mLOY on lung cancer could be biased by smoking status. In addition, the ordinary observational case-control studies cannot evaluate the causal relationship between mLOY and lung cancer.
Mendelian randomization provides an alternative approach to unbiasedly infer the causal relationship between exposure and outcome with genetic variants 9 that can be easily and accurately detected in a largescale epidemiological study. Recently, a genome-wide association study (GWAS) was conducted to comprehensively evaluate the genetic influence on individual mLOY on the basis of a large-scale cohort. 5 These findings provided us with genetic markers that could be used to investigate the association between mLOY and risk of lung cancer by using the mendelian randomization approach.
To systematically investigate the causal relationship between mLOY and lung cancer, we conducted a standard mendelian randomization study by using the novel mLOY-associated variants reported by Wright et al. 5 as instrumental variables. We first evaluated the association between genetically predicted mLOY and lung cancer risk in 3797 males (1711 case patients and 2086 controls) from our previous Nanjing Medical University lung cancer GWAS data 10 and then directly investigated the association of individual copy numbers of chromosome Y with lung cancer risk in 2255 males (1445 case patients and 810 controls). Kaplan-Meier and Cox regression analyses were performed to evaluate the effect of mLOY on lung cancer prognosis in 309 patients with lung cancer treated without surgery.
Materials and Methods

Study Population
We conducted a mendelian randomization study to evaluate the association between mLOY and lung cancer risk. The study population was derived from our previous lung cancer GWAS. 10 This study obtained informed consent from all of the included subjects and was approved by the ethics and human subject committee of Nanjing Medical University. We included data on 3797 males (1711 case patients and 2086 controls) to examine the association between genetically predicted mLOY and lung cancer risk; the demographics of this population are described in Supplementary Table 1 . First, we estimated the median of the log R ratio (LRR) of probes in the Y chromosome (mLRR-Y) in 2255 males (1445 case patients and 810 controls) included in samples from the aforementioned 3797 males with available raw array data and validated the association between mLOY-related single-nucleotide polymorphism (SNPs) and mLRR-Y in 810 control subjects. We further studied the association between mLRR-Y and lung cancer risk directly in the 2255 males (Fig. 1) . Then, we derived a weighted genetic risk score (wGRS) to predict mLOY and evaluate its association with lung cancer risk in 3797 males. Survival analysis was conducted in 309 nonoperatively managed male patients included in the aforementioned 1711 case patients with available follow-up and clinical information (see Supplementary  Table 1 ). All case patients were males who were histopathologically or cytologically confirmed to have lung cancer by at least two local pathologists. Cancer-free control subjects were randomly selected from those receiving routine physical examinations in local hospitals or those participating in a community-based screening program for noninfectious diseases in Jiangsu Province. The details have been described in our previous work. 
Quality Control and Imputation
All subjects included in this study were genotyped with Affymetrix Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA), and we obtained genotype data by either direct genotyping or imputation. To obtain high-quality genotype data, we performed a standard quality control procedure with PLINK software (version 1.07, http://zzz.bwh.harvard.edu/plink/) to exclude unqualified SNPs and samples. Unqualified SNPs were those that did not map to autosomal chromosomes with a call rate lower than 95% and minor allele frequency (MAF) less than 0.05 and deviated from HardyWeinberg equilibrium in all samples (p < 1 Â 10 -5 ).
The unqualified samples (1) had a call rate lower than 95%, (2) had sex discordance, (3) were duplicates or probable relatives, (4) 
Selection of mLOY-Related SNPs
Wright et al. 5 recently conducted a GWAS in 85,542 men with European ancestry and identified 19 genomic regions associated with mLOY at a genome-wide significance level (p < 5 Â 10 -8
). We first excluded five variants with an MAF less than 0.05 in the Chinese population; four indels were further excluded owing to the failure of imputation and were replaced by SNPs with high linkage disequilibrium (r 2 > 0.90) (Supplementary Table 2 ). The MAF and linkage disequilibrium were estimated in the Han Chinese in Beijing population from the 1000 Genomes Project phase 3 data. The four indels were rs10687116, rs137952017, rs59633341, and rs35091702, and they were replaced by rs9805742 (r 2 ¼ 0.946, Is ¼ 0.97), rs10151519 (r 2 ¼ 1.000, Is ¼ 0.99), rs6802910 (r 2 ¼ 1.000, Is ¼ 0.97), and rs6468341 (r 2 ¼ 1.000, Is ¼ 0.99), respectively.
Estimating Mosaic Y Chromosome Loss
We estimated the level of mLOY according to the LRR of probes in the male-specific region of chromosome Y, which is located in the 56-Mb region between pseudoautosomal regions 1 and 2 (PAR1 and PAR2, Y chromosome: 2,694,521-59,034,049, hg19/GRCh37), in 2255 males (1445 case patients and 810 controls) from the aforementioned 3797 male samples with available raw array data. The signal intensity, genotype call, and confidence files derived from the Affymetrix Power Tools software were further analyzed with the PennCNV-Affy pipeline software and produced the LRR for each probe. Assuming that the total variation in mLRR-Y consisted of signals from both mLOY and experimental factors, we further excluded the influence of these factors as previously described. 4 We first determined the peak of the histogram of mLRR-Y with a kernel density estimation method implemented in the density function of R and use of the bandwidth SJ. Then, the bin with the highest value in the smoothed distribution was selected as the local median, and the observations in the positive tail were mirrored over the kernel-derived median to create the negative tail. Finally, for the most conservative estimate of the frequency of mLOY, the lowest value in the simulated noise distribution was used as the threshold. 4 
Statistical Analysis
We created a wGRS to predict mLOY for mendelian randomization by summing the dosage of 14 independent mLOY-increasing alleles with the following formula:
, where bi is the estimated effect of the i-th SNP for mLOY from the previous study 5 and SNP i is the dosage (coded as 0, 1, or 2 for wild-type homozygous, heterozygous, or homozygous, respectively) of the effect allele which is associated with increasing mLOY.
We performed linear regression to evaluate the association between mLRR-Y and each of the 14 SNPs in the controls, adjusting for age and smoking status. A restricted cubic spline function was applied to examine the shape of the association of the genetically predicted mLOY and mLRR-Y with lung cancer risk, and the Wald test was used for the nonlinearity estimation. The association between genetically predicted mLOY and lung cancer risk was estimated by logistic regression analysis, assuming an additive effect of the allele dosage on the log odds scale adjusted for age, pack-years of smoking, and the first PC. Stratification analysis was performed by known factors that could influence individual mLOY levels, including age and smoking status. The Cochran Q statistic was calculated to test for heterogeneity in two subgroups.
To determine the robustness of the association between genetically predicted mLOY and lung cancer risk, we performed sensitivity analysis with both the unweighted genetic risk score (GRS) and the inverse variance-weighted method. The GRS was calculated by summing the dosage of 14 independent mLOYincreasing alleles with the following formula: GRS ¼ P 14
The inverse variance-weighted regression was applied to examine the potential causal association between mLOY (X) and lung cancer risk (Y) with mLOYrelated SNPs as the instrumental variables. 11 Briefly, the causal effect (b YX ) between mLOY and lung cancer risk was evaluated with the Wald estimator:
, where b YG is the estimated effect for lung cancer associated with the instrumental variable and b XG is the estimated effect for mLOY associated with the instrumental variable obtained from the previous GWAS. 5 Although the SE for mLOY associated with the instrumental variable was not provided in the reported GWAS, we calculated S XG with the following formula :
, where S XG and S YG are the corresponding SEs. We also performed mendelian randomization-Egger regression analysis to estimate the potential pleiotropic effect of the mLOYrelated genetic variants. 13 A multivariate Cox proportional hazards regression model was used to estimate the hazard ratios (HRs) and their 95% confidence intervals (CIs), adjusting for age, pack-years of smoking, and tumor stage. General statistical analyses were performed with R software (version 3.2.2). Two-sided p values less than 0.05 were considered statistically significant.
Results
Genetically Predicted mLOY Is Associated with mLRR-Y
A total of 14 mLOY-related SNPs were included in the analysis after exclusion of five variants with MAF less than 0.05 in the Chinese population. We created a wGRS to predict mLOY by summing the dosage of 14 independent mLOY-increasing alleles (see Supplementary  Table 2) .
We first estimated mLRR-Y as a proxy of the copy number of the Y chromosome in 810 healthy male participants; the association between 14 reported mLOY-related SNPs and mLRR-Y is shown in Supplementary Table 3 . A significant negative correlation between genetically predicted mLOY and mLRR-Y was observed, whereas individuals carrying greater numbers of mLOY-increasing alleles had a significantly lower mLRR-Y (b ¼ -0.58, p ¼ 3.38 Â 10 À2 ) ( Fig. 1 and Supplementary Fig. 1 Fig. 2A and B).
Genetically Predicted mLOY Is Associated with a Decreased Lung Cancer Risk
We provide the 14 mLOY-related genetic variants and their effect on lung cancer risk from our lung cancer GWAS data in Supplementary Table 3 . We performed a logistic regression analysis to evaluate the association between genetically predicted mLOY and lung cancer risk in 3797 males (1711 case patients and 2086 controls). After controlling for age, smoking status, and the first PC, we found that increased genetically predicted mLOY was significantly associated with a decreased risk of lung cancer (per SD increase in the wGRS: OR ¼ 0.92, 95% CI: 0.86-0.98, p ¼ 1.30 Â 10 -2
) (see Fig. 1 and Supplementary Fig. 3 ). The more interesting result was that the protective effect was observed in lifelong nonsmokers but not in smokers ( ) ( Table 1 ), suggesting that smoking behavior dramatically abolished the protective effect of mLOY against lung cancer.
Because smoking behavior and increasing age contribute to the generation of mLOY and the risk of lung cancer, we further investigated whether mLOY caused by damaging environmental factors was different from genetically defined mLOY. As expected, we observed that genetically predicted mLOY was not associated with smoking status or age ( Supplementary Fig. 2C and D) , whereas the individual mLRR-Y level was significantly greater in lifelong nonsmokers and the younger population than in smokers and the older population (see Supplementary Fig. 2A and B) . More interestingly, whereas genetically predicted mLOY was linearly associated with a decreased lung cancer risk (p for linearity Wald ¼ 0.15) (see Fig. 2A ), a U-shaped curve was fitted between mLRR-Y and lung cancer risk (p for linearity Wald ¼ 8.81 Â 10 -10 ) (Fig. 2B ).
Genetically Predicted mLOY Is Associated with a Better Lung Cancer Prognosis
To further evaluate the effect of mLOY on lung cancer prognosis, we performed a multivariate Cox proportional hazard regression analysis in 309 male patients with lung cancer treated without surgery. Interestingly, we found that increased genetically mLOY was significantly associated with a better prognosis after controlling for age, smoking status, and tumor stage (crude HR ¼ 0.87, Fig. 3]) , whereas no association existed between individual mLRR-Y levels and lung cancer outcome (p ¼ 3.88 Â 10 -1 ). Additionally, patients carrying high genetically predicted mLOY had a longer median survival time (14.07 months) than did patients with low genetically predicted mLOY (11.27 months).
Sensitivity Analysis Using Alternative Causal Inference Methods
We further evaluated the association between 14 SNPs and lung cancer risk in our case-control study to infer whether any of the individual genetic variants used in our wGRS drove this result (Supplementary Table 3) ; however, none of these SNPs had significant associations with lung cancer risk, and no heterogeneity was observed (p for a Cochran Q test value of 0.76). The aforementioned result suggested that the effect estimated from the genetically predicted mLOY was not driven by any single SNP.
To test the robustness of our primary result, we further evaluated the association between genetically predicted mLOY and lung cancer by using several additional methods (see Supplementary Fig. 3 ). First, we constructed an unweighted risk score with the aforementioned 14 SNPs and found a consistent association with the results derived from wGRS (per SD increase: OR ¼ 0.92, 95% CI: 0.86-0.98, p ¼ 1.35 Â 10 -2 ), suggesting that the choice of weights used in the wGRS method was robust. Then, we obtained both weighted and unweighted median estimates for the causal effect using all of the aforementioned genetic variants. The causal effect generated by this approach was similar to that generated by the aforementioned GRS approach (per SD increase in unweighted median-based estimate: ). To further evaluate the potential pleiotropic effect of the genetic instruments used in this study, we performed mendelian randomization-Egger regression analysis. However, we observed no evidence of bias (p ¼ 0.66) (see Supplementary Figs. 3 and 4) , and the direction of bias that we estimated was negative, suggesting that the effect of the putative bias present across the selected genetic variants resulted in an underestimation of the causal effect on lung cancer risk (see Supplementary Fig. 4 ).
Discussion
Chromosome Y has long been recognized for its necessity in sex determination and male sperm cell development. [15] [16] [17] However, genomic characterization of chromosome Y still lags far behind that of the rest of the genome because it is considered to be a wasteland. Recently, as a male-specific genomic event, mLOY was found to frequently occur in aging men 1 and shown to be associated with smoking status and increased hypodiploidy. 1, [18] [19] [20] Population-based studies have also identified associations between mLOY and hematological disorders and nonhematological malignancies 2,4-6 ; however, these results are inconsistent and may be confounded by reverse causality. [4] [5] [6] In this study, we have provided what to our knowledge is the first evidence for a causal relationship between mLOY and lung cancer based on the concept of mendelian randomization. Sensitivity analyses with alternative casual inference methods demonstrated a consistent association, suggesting the robustness of our results. We propose that mLOY is a protective factor against both the tumorigenesis and progression of lung cancer, whereas cigarette smoking may weaken this effect. Together with the results of previous studies, our findings support the idea that chromosome Y carries many vital functions in biological processes beyond sex determination and sperm production.
In this study, one of the most noteworthy findings was a U-shaped curve between the copy number level of chromosome Y and lung cancer risk, whereas genetically defined mLOY was linearly associated with a decreased lung cancer risk. Additionally, we have also provided the first evidence that increased genetically predicted mLOY can lead to better prognosis of lung cancer. This result suggests that genetically defined mLOY is different from mLOY caused by environmental factors. Although genetically defined mLOY may promote benign aneuploidy and exert a protective factor against lung cancer, both gain and loss of chromosome Y caused by acquired damaging environmental factors may contribute to spontaneous tumorigenesis. As a well-known risk factor for lung cancer, 21 tobacco carcinogen is reported to increase copy number alterations and large-scale chromosomal instability in lung cancer, [22] [23] [24] and smoking can also induce mLOY in the blood in a dose-dependent and transient manner. 8 Thus, we believe that the effect of cigarette smoking may bias the estimation of mLOY.
Given the aforementioned results, we thoroughly tested whether cigarette smoking confounded the effect of mLOY on lung carcinogenesis. Interestingly, the protective effect of mLOY against lung cancer was observed in lifelong nonsmokers but not in smokers (p Heterogeneity ¼ 3.83 Â 10 -2 ) (see Table 1 ). These findings suggest that the aberrant loss of chromosome Y occurs more frequently in smokers than in nonsmokers and exerts an effect on lung cancer that is the opposite of that of genetically defined mLOY. Therefore, cigarette smoking may account for most of the environmental damaging effects of mLOY during the process of lung carcinogenesis. Additionally, on the basis of the assumption of mendelian randomization, all of the mLOY-associated genetic variants used in this study were not associated with smoking behavior, and hence, the bias caused by smoking status could be avoided. On the basis of the aforementioned hypothesis, it is reasonable to observe a relatively weaker protective effect of mLOY against lung cancer than that observed by Zhou et al. 6 because of the relatively low smoking rate in the Asian population than in Europeans. 25 Although genetically predicted mLOY was found to be a protective factor against lung cancer, the effect can be easily attenuated by external risk factors, which may account for the higher incidence and mortality of most non-sexspecific cancers in males. However, the phenotypic consequence of mLOY in the development of lung cancer is rather elusive and further functional studies in both cellular and animal systems are warranted to elucidate the exact mechanism. As cancers are heterogeneous in their origin and may be caused by different forms of exposure, we believe that the inconsistent associations found between mLOY and cancer risk in previous studies can be attributed to the underestimation of caner heterogeneity and the effect of environmental factors.
In summary, we propose that mLOY has two sides. Natural mLOY reduces lung cancer risk and predicts a better prognosis, although its effects can be abolished by aberrant loss of chromosome Y caused by environmental risk factors. This finding is of great clinical importance for risk stratification and has implications for the prevention of lung cancer.
